about
A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteinsPurification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNAEpigenetic silencing in embryogenesisKaiso is a genome-wide repressor of transcription that is essential for amphibian developmentThe genome-defence gene Tex19.1 suppresses LINE-1 retrotransposons in the placenta and prevents intra-uterine growth retardation in miceNon-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylomeA gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykMicroarray analysis of LTR retrotransposon silencing identifies Hdac1 as a regulator of retrotransposon expression in mouse embryonic stem cells.Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes.An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer.A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth.The effect of interspecific oocytes on demethylation of sperm DNA.Lashings of DNA methylation, forkfuls of chromatin remodeling.Genomic insights into cancer-associated aberrant CpG island hypermethylationTranscriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.From paramutation to paradigmDNA methylation in animal development.Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline.Targeting of Rac GTPases blocks the spread of intact human breast cancer.Tissue of origin determines cancer-associated CpG island promoter hypermethylation patternsDynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver.Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer.Defending the genome from the enemy within: mechanisms of retrotransposon suppression in the mouse germlineNon-canonical functions of the DNA methylome in gene regulation.Epigenetic reprogramming: preparing the epigenome for the next generation.Epigenetic profiles as defined signatures of xenobiotic exposure.Investigating 5-hydroxymethylcytosine (5hmC): the state of the art.5-hydroxymethylcytosine profiling as an indicator of cellular state.Genetic and physical mapping of a gene encoding a methyl CpG binding protein, Mecp2, to the mouse X chromosome.Comparative analysis of affinity-based 5-hydroxymethylation enrichment techniques.Senescent cells harbour features of the cancer epigenome.Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genesDNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage response.The interaction of xKaiso with xTcf3: a revised model for integration of epigenetic and Wnt signalling pathways.Putting muscle in DNA methylation.Apoptosis and DNA methylation.Cloning and developmental expression of MARK/Par-1/MELK-related protein kinase xMAK-V in Xenopus laevis.LINE-1 activation and epigenetic silencing of suppressor genes in cancer: Causally related events?Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA.
P50
Q28242685-2354546C-EEE1-461E-96A8-A311C2BD28A1Q28265233-73149238-B6B0-4AA5-B677-0C1C078DECA6Q28268229-DCF7E03E-4BAD-4E11-866A-FBF7A10C94DEQ28293919-62AEA895-01ED-4997-A71A-217B299A88CBQ28585479-50E54172-8E10-4CB6-8EC3-51C3311D2105Q28714223-BB42C745-1004-419B-BCFF-0019746AA2FAQ30496002-89E44A18-D9A2-45B9-ADAE-DA490F80AD08Q31061401-2EE8A63B-DBED-47DB-B640-F10F9F69243CQ33741844-53B58732-5EDA-4851-8332-FE262D1BC05CQ33828295-F22C57F3-EEAE-49D1-8627-53979F4E5AE4Q33973072-98B169D0-156C-48E8-9E94-5D31CEC5B2C4Q34277852-E7DAE5B5-53E6-47F3-8EC1-44765A0CC33FQ34336525-CBCF1701-CFBD-411F-A11B-DCA23B25D0E5Q34467396-64EC519B-20C7-4194-948A-590028E817B6Q34647477-0BBB24A3-060C-438C-B1E7-F1982D664B6DQ34694010-84EEA272-1266-4D13-BB91-6773B54CACBCQ34743793-1C5351DE-F3B0-4662-9B56-63598800DD3BQ35043702-09E058F3-3EE8-4994-A234-57B7C1BBC426Q36215760-094EB4D4-AC6A-4209-941B-9C243BA03B6DQ36234042-4756DDB0-1364-4B38-89F1-8364504171D1Q36378085-B8033802-1DBB-4A0E-A7CA-27A60281ACC1Q36909743-38257B22-581E-418C-BA05-71FA3E8E57ADQ37080366-4115B301-4AA4-49AA-B367-C269FF5D9C89Q37698311-09091BC2-B44D-4773-B61C-B1DD6A25E2E0Q38089266-6F6A84A0-52B9-4642-872F-0D56F692C9FAQ38108672-15A702E5-2B39-4DC4-BA3C-7182570AAA85Q38133900-33CD787A-8A85-4813-A120-B8E6C6434852Q38155809-7EA1CB5B-20B7-43F0-A07C-B0974767B767Q38166838-ACCC1329-7B5A-4825-86F2-B6C45A55A562Q38305810-D2DFA896-BE1E-45BF-ABF4-A2365A5AF5CFQ38311310-D28D9467-5BE8-4C16-A3C8-688F4F290445Q39056256-A5647E77-CCAB-47EE-B3E2-BA45A181D3FDQ39439009-C7D33C55-3CC1-4C11-84B0-C0F0E0660C48Q39531551-900D005D-548D-4502-8CFA-4ACCDD3CD43AQ41823904-C0337103-7865-4A4E-8BA1-5954773C122BQ41967315-2392020A-C0BB-45D4-8404-94B822C57343Q42576933-6971BA2D-B3DC-4AC6-B9B0-0BEC129EC4C7Q42617961-D6D747A0-B617-4481-8276-398844FC8C6FQ42908408-D073E556-A178-49D5-96C8-696F76529A84Q43009515-84553945-E1AE-4580-A528-B2BB1A55F3DA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Richard Meehan
@ast
Richard Meehan
@en
Richard Meehan
@es
Richard Meehan
@nl
Richard Meehan
@sl
type
label
Richard Meehan
@ast
Richard Meehan
@en
Richard Meehan
@es
Richard Meehan
@nl
Richard Meehan
@sl
prefLabel
Richard Meehan
@ast
Richard Meehan
@en
Richard Meehan
@es
Richard Meehan
@nl
Richard Meehan
@sl
P106
P1153
7004996674
P21
P31
P496
0000-0001-6471-6882